Cookie Img
Home » Products » Pharmaceutical Tablets » Velasof Tablets

Velasof Tablets

Velasof Tablets
Velasof Tablets
Send Inquiry
Product Code : 00
Product Specifications
  • Formulations Type
  • Chemical Drug
  • Formulations Form
  • Tablets
  • Gender/Age Group
  • Adult
Product Description
Technical Details:
  • Brand Name: Velasof
  • Manufacturer: Hetero
  • Ingredients: Velpatasvir 100 mg, Sofosbuvir 400 mg
  • Type: Tablet

Velasof tablet is composed of sofosbuvir and velpatasvir. It is used for treatment of chronic hepatitis C, a viral contagion of the liver. Such drugs functions by reducing the quantity of hepatitis C virus in the body.

Velasof (Sofosbuvir 400 mg and velpatasvir 100 mg) is taken alone or in combination with ribavirin to cure chronic hepatitis C. Sofosbuvir is from the class of antiviral medicines known as nucleotide hepatitis C virus NS5B polymerase inhibitors and Velpatasvir is from the class of antiviral medicines known as HCV NS5A repetition complex inhibitors.

The mixture of sofosbuvir and velpatasvir functions by discontinuing the virus that results in hepatitis C from scattering inside the body.

COMMON SIDE EFFECTS:

Common Velasof side effects includes: tired feeling; headache; diarrhea; nausea, or sleep problems (insomnia).

Contact your doctor immediately if you have:
  • Weak or shallow breathing; or
  • Slow heartbeats;
  • Low red blood cells or pale skin, rapid heart rate, weakness, trouble concentrating.
  • If you also use amiodarone: pursue medical help instantly if you feel tired, weak, or light-headed, also if you suffer chest pain, confusion, shortness of breath or memory problems.
Trade Information
  • Payment Terms
  • Cash Advance (CA), Delivery Point (DP), Western Union
  • Sample Available
  • Yes
  • Main Export Market(s)
  • Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
  • Main Domestic Market
  • All India

JOHNLEE PHARMACEUTICALS PVT. LTD.
X


JOHNLEE PHARMACEUTICALS PVT. LTD. All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Ltd.